Clinical Trials Directory

Trials / Completed

CompletedNCT03947554

Ginseng HRG80 in Stress and Fatigue

Study of the Efficacy of Panax Ginseng Herbal Preparation HRG80 for Prevention and Mitigation of the Symptoms of Stress in Healthy Subjects

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
50 (actual)
Sponsor
EuroPharma, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effects of a specific herbal preparation of Panax ginseng in preventing symptoms of stress in healthy individuals.

Detailed description

HRG80 is an herbal preparation of Panax ginseng with a higher concentration of bioavailable ginsenosides than typical Korean ginseng. This study will test whether HRG80 is effective at preventing symptoms of stress, such as fatigue, impaired memory, difficulty in concentration, attention deficit, restlessness, and irritation related to daily work situations of healthy individuals in comparison to placebo and a standard Pananx ginseng with a lower concentration of ginsenosides.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHRG80 Panax ginsengPanax ginseng containing 63.4 mg ginsenosides
DIETARY_SUPPLEMENTPanax ginsengPanax ginseng containing 19.6 mg ginsenosides
DIETARY_SUPPLEMENTPlacebo800 mg excipient

Timeline

Start date
2019-04-01
Primary completion
2019-06-15
Completion
2019-07-01
First posted
2019-05-13
Last updated
2019-07-05

Locations

1 site across 1 country: Armenia

Source: ClinicalTrials.gov record NCT03947554. Inclusion in this directory is not an endorsement.